Tumour type and treatment | Distance from blood vessel at which fluorescence falls to 50% its original value (L) | Doxorubicin distribution (μm × I) | Microvascular Density |
---|---|---|---|
HCT-8Ea | 24 ± 5 | 785 ± 190 | 3.0 ±0.5 |
HCT-8Ra | 31 ± 6 | 1476 ± 370* | 6.0 ± 0.8 |
HCT-8Ea & Bortezomib pre-treatment | 29 ±7 | 1140 ± 190* | 2.6 ± 0.3 |
HCT-8E11 | 29 ± 8 | 990 ± 220 | 4.1 ± 0.4 |
HCT-81R1 | 43 ± 11 | 2097 ± 248** | 2.8 ± 0.2 |
HCT-8E11 & Bortezomib pre-treatment | 35 ± 9 | 1170 ± 200** | 3.8 ± 0.6 |